|
|
||||||||
a Cardiac Surgery, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
b Cardiology Department, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
c Biostatistics Department, McGill University Health Centre, Montreal, Quebec, Canada
Accepted for publication November 20, 2008.
* Address correspondence to Dr Perrault, Institut de Cardiologie de Montréal, 5000 rue Bélanger, Montreal, Quebec, H1T 1C8, Canada (Email: louis.perrault{at}icm-mhi.org).
Background: We reviewed our experience at the Montreal Heart Institute with early surgical and percutaneous closure of postinfarction ventricular septal defects (VSD).
Methods: Between May 1995 and November 2007, 51 patients with postinfarction VSD were treated. Thirty-nine patients underwent operations, and 12 were treated with percutaneous closure of the VSD.
Results: Half of the patients were in systemic shock, and 88% were supported with an intraaortic balloon pump before the procedure. Before the procedure, 14% of patients underwent primary percutaneous transluminal coronary angioplasty. The mean left ventricular ejection fraction was 0.44 ± 0.11, and mean Qp/Qs was 2.3 ± 1. Time from acute myocardial infarction to VSD diagnosis was 5.4 ± 5.1 days, and the mean delay from VSD diagnosis to treatment was 4.0 ± 4.0 days. A moderate to large residual VSD was present in 10% of patients after correction. Early overall mortality was 33%. Residual VSD, time from myocardial infarction to VSD diagnosis, and time from VSD diagnosis to treatment were the strongest predictor of mortality. Twelve patients were treated with a percutaneous occluder device, and the hospital or 30-day mortality in this group was 42%.
Conclusion: Small or medium VSDs can be treated definitively with a ventricular septal occluder or initially to stabilize patients and allow myocardial fibrosis, thus facilitating delayed subsequent surgical correction.
Related Article
Ann. Thorac. Surg. 2009 87: 693.
This article has been cited by other articles:
![]() |
M. Muscat, E. Laverse, Z. Haq, A. A. Chahal, and J. Akhtar Acute ischaemic ventricular inferoseptal defect in a pyretic patient: a diagnostic challenge BMJ Case Reports, December 8, 2011; 2011(dec08_1): bcr0720114452 - bcr0720114452. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Attia and C. Blauth Which patients might be suitable for a septal occluder device closure of postinfarction ventricular septal rupture rather than immediate surgery? Interact CardioVasc Thorac Surg, November 1, 2010; 11(5): 626 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Lee, R. Kozitza, D. Mudrick, M. Williams, A. J. Lodge, J. K. Harrison, and D. D. Glower Intraoperative Device Closure of Postinfarction Ventricular Septal Defects Ann. Thorac. Surg., June 1, 2010; 89(6): e48 - e50. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Pagani Invited Commentary Ann. Thorac. Surg., March 1, 2009; 87(3): 693 - 693. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |